TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/24/20 21:19 | 6/23/20 | FMTX | Forma Therapeutics Holdings, Inc., | DE | Health | BioPrd | Biological Products, (No Diag | Kolchinsky Peter | MA | DT | P.d | 80,000 | 20.00 | 0 | 4,000 | 80 | 9,012 | I | |||||||||||||||
12/2/19 16:30 | 11/27/19 | DRNA | Dicerna Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Kolchinsky Peter | MA | D | S.m | -15,634 | 24.28 | 0 | -644 | -100 | 0 | I | ||||||||||||||||
11/26/19 17:23 | 11/22/19 | DRNA | Dicerna Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Kolchinsky Peter | MA | D | S.m | -18,795 | 23.53 | 0 | -799 | -55 | 644 | I | ||||||||||||||||
11/21/19 17:02 | 11/19/19 | DRNA | Dicerna Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Kolchinsky Peter | MA | D | S.m | -23,667 | 23.34 | 0 | -1,014 | -41 | 1,442 | I | ||||||||||||||||
12/13/18 18:31 | 12/11/18 | THOR | Synthorx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kolchinsky Peter | MA | DT | P.d | 50,000 | 11.00 | 0 | 4,545 | 88 | 9,725 | I | |||||||||||||||
12/20/17 20:37 | 12/18/17 | DRNA | Dicerna Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kolchinsky Peter | MA | D | M.d | 0 | 0.00 | 0 | 2,645 | 109 | 5,074 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |